Tromsø, Norway, April 18nd 2023 - ArcticZymes Technologies ASA (OSE:AZT)
announces the launch of ArcticZymes Proteinase HQ to the B2B market.
Following up on earlier press-releases (9[th] Dec 2022) ArcticZymes is pleased
to launch the latest member in our Proteinase product portfolio: ArcticZymes
Proteinase HQ.
This product is the 'bioprocessing grade' version of our existing successful
ArcticZymes Proteinase and will be made available to the B2B market i.e., large
scale supply to business customers developing their own industrial processes.
Bioprocessing grade includes features specifically demanded by customers in the
biomanufacturing segment; for example, a more comprehensive quality
documentation package to include, among others, statements pertaining to
endotoxins, bioburden and non-animal origin inputs.
ArcticZymes Technologies ASA, CSO, Darren Ellis said:
"This enzyme is quite a distinct alternative to existing commercial enzymes and
its performance characteristics and area of application should not be confused
with those of, for example, proteinase K. Proteinase K will quickly reduce
proteins to short fragments and destroy information, whereas our enzyme is
significantly more gentle and is an excellent choice when the goal is to reduce
protein load to improve handling and sample accessibility without destroying all
the associated biological information. These novel features expand the design
choices for our customers to resolve certain technical barriers in both
molecular and biomanufacturing workflows."
For more information, please contact:
ArcticZymes Technologies
CSO, Darren Ellis Tel: +47 47 31 50 07
CFO, Børge Sørvoll Tel: +47 95 29 01 87
ir@arcti
czymes.com
About ArcticZymes Technologies ASA
ArcticZymes Technologies is a Norwegian life sciences company focused on the
development, manufacturing and commercialization of novel recombinant enzymes
for use in molecular research, In Vitro Diagnostics (IVD) and biomanufacturing.
The company is listed on the Oslo Stock Exchange since 2005 as ArcticZymes
Technologies under the [AZT] ticker. Its headquarters are based in Tromsø,
Norway, at the SIVA Innovation Centre.
ArcticZymes Technologies' IP and capabilities are protected via a large
portfolio of patents.
For more information, please visit the website: www.arcticzymes.com.